Form 13-F position report

BIOGEN INC

Reported by NORTHERN TRUST CORPORATION

BIIB CUSIP 09062X103 Manager CIK 0000073124

Reported 1,536,980 shares, up 35,893 (2.4%) from the prior quarter.

Reported value -6.0%; share count 2.4% vs. the prior quarter.

Added
% of reported 13F value 0.03% This manager · Q2 2025
Shares 1,536,980 Quarter-end amount reported
Reported value $193,029,318 Fair value at quarter end
Consecutive quarters held 49 Through Q2 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 405973000
2022-03-31 354972000
2022-06-30 348651000
2022-09-30 449901000
2022-12-31 462918579
2023-03-31 464668481
2023-06-30 455075789
2023-09-30 422276425
2023-12-31 386851576
2024-03-31 299377674
2024-06-30 330557006
2024-09-30 262291688
2024-12-31 237045881
2025-03-31 205408747
2025-06-30 193029318
2025-09-30 210026427
2025-12-31 254503714
2026-03-31 265201330
2026-06-30 308855610
2026-09-30 324198561

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for BIOGEN INC held by NORTHERN TRUST CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 1,435,269 +5,779 (0.4%) 0.04% $324,198,561 2026-11-16
Q2 2026 Reduced 1,429,490 -17,089 (-1.2%) 0.04% $308,855,610 2026-08-13
Q1 2026 Added 1,446,579 +453 (0.0%) 0.04% $265,201,330 2026-05-14
Q4 2025 Reduced 1,446,126 -53,206 (-3.5%) 0.03% $254,503,714 2026-02-17
Q3 2025 Reduced 1,499,332 -37,648 (-2.4%) 0.03% $210,026,427 2025-11-14
Q2 2025 Added 1,536,980 +35,893 (2.4%) 0.03% $193,029,318 2025-08-13
Q1 2025 Reduced 1,501,087 -49,043 (-3.2%) 0.03% $205,408,747 2025-05-13
Q4 2024 Added 1,550,130 +196,995 (14.6%) 0.03% $237,045,881 2025-02-14
Q3 2024 Reduced 1,353,135 -72,786 (-5.1%) 0.04% $262,291,688 2024-11-13
Q2 2024 Added 1,425,921 +37,535 (2.7%) 0.06% $330,557,006 2024-08-14
Q1 2024 Reduced 1,388,386 -106,577 (-7.1%) 0.05% $299,377,674 2024-05-14
Q4 2023 Reduced 1,494,963 -148,072 (-9.0%) 0.07% $386,851,576 2024-02-13
Q3 2023 Added 1,643,035 +45,437 (2.8%) 0.08% $422,276,425 2023-11-13
Q2 2023 Reduced 1,597,598 -73,691 (-4.4%) 0.09% $455,075,789 2023-08-11
Q1 2023 Reduced 1,671,289 -380 (0.0%) 0.09% $464,668,481 2023-05-15
Q4 2022 Reduced 1,671,669 -13,352 (-0.8%) 0.1% $462,918,579 2023-02-13
Q3 2022 Reduced 1,685,021 -24,556 (-1.4%) 0.1% $449,901,000 2022-11-14
Q2 2022 Added 1,709,577 +24,050 (1.4%) 0.07% $348,651,000 2022-08-12
Q1 2022 Reduced 1,685,527 -6,595 (-0.4%) 0.06% $354,972,000 2022-05-13
Q4 2021 Reduced 1,692,122 -66,768 (-3.8%) 0.07% $405,973,000 2022-02-08
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

969 managers reported BIOGEN INC for Q2 2025.

Managers reporting BIOGEN INC in Q2 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 17,290,651 +257,812 0.04% $2,171,532,858 49 qtrs
PRIMECAP MANAGEMENT CO CA Reduced 15,802,122 -141,137 1.57% $1,984,588,503 49 qtrs
BlackRock Inc Reduced 13,555,466 -1,655,570 0.03% $1,702,431,056 4 qtrs
STATE STREET CORPORATION Added 7,468,807 +71,897 0.04% $938,007,471 49 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 4,798,420 +125,983 0.11% $602,633,568 49 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 3,918,150 +71,286 0.03% $490,089,204 49 qtrs
Point72 Asset Management L P Added 3,831,727 +3,424,470 0.94% $481,226,574 2 qtrs
Invesco Ltd Added 2,320,126 +55,119 0.05% $291,384,624 49 qtrs
NORGES BANK Added 2,264,177 +110,791 0.04% $284,357,989 49 qtrs
MORGAN STANLEY Reduced 1,956,210 -34,458 0.02% $245,680,815 49 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2025
Filed
August 13, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,505,135
Shared
28,960
None
2,885

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.